{
    "Trade/Device Name(s)": [
        "Dimension Vista APOA1 Flex reagent cartridge",
        "Dimension Vista APOB Flex reagent cartridge",
        "Dimension Vista Apolipoprotein Calibrator",
        "Dimension Vista Apolipoprotein Control"
    ],
    "Submitter Information": "Dade Behring Marburg GmbH",
    "510(k) Number": "K063608",
    "Predicate Device Reference 510(k) Number(s)": [
        "K860894",
        "K041870",
        "K993310"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MSJ",
        "JIX",
        "JJY"
    ],
    "Summary Letter Date": "February 23, 2007",
    "Summary Letter Received Date": "December 04, 2006",
    "Submission Date": "December 01, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Apolipoprotein A-I",
        "Apolipoprotein B"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochemical assay",
        "Turbidimetric measurement"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista APOA1/ APOB Flex reagent cartridges, calibrator, and control for apolipoprotein A-I and B quantification on Dimension Vista System",
    "Indications for Use Summary": "Quantitative determination of apolipoprotein A-I and B in human serum or plasma to aid diagnosis and treatment of lipid disorders, liver and renal diseases, and assessment of atherosclerosis and cardiovascular disease risk",
    "fda_folder": "Clinical Chemistry"
}